NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Stok Raporu

Piyasa değeri: US$3.7m

NovaBay Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 3/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Justin Hall

İcra Kurulu Başkanı

US$364.1k

Toplam tazminat

CEO maaş yüzdesi96.1%
CEO görev süresi8.9yrs
CEO sahipliği0.001%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi4.1yrs

Son yönetim güncellemeleri

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

CEO Tazminat Analizi

Justin Hall'un ücretlendirmesi NovaBay Pharmaceuticals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$17m

Mar 31 2024n/an/a

-US$19m

Dec 31 2023US$364kUS$350k

-US$17m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$365kUS$350k

-US$16m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$796kUS$329k

-US$7m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$747kUS$286k

-US$11m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$326kUS$260k

-US$10m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$572kUS$260k

-US$7m

Sep 30 2018n/an/a

-US$4m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$665kUS$228k

-US$7m

Tazminat ve Piyasa: Justin's total compensation ($USD364.15K) is below average for companies of similar size in the US market ($USD655.65K).

Tazminat ve Kazançlar: Justin's compensation has been consistent with company performance over the past year.

CEO

Justin Hall (46 yo)

8.9yrs

Görev süresi

US$364,146

Tazminat

Mr. Justin M. Hall, Esq. has been General Counsel at NovaBay Pharmaceuticals, Inc. since December 2015, Corporate Secretary since July 16, 2017 and President and Chief Executive Officer since June 17, 2019...

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Justin Hall
President4.3yrsUS$364.15k0.0014%
$ 50.9
Paul Freiman
Independent Chairman22.5yrsUS$78.08k0.0016%
$ 57.9
Yenyou Zheng
Independent Director5.2yrsUS$74.08k0.0015%
$ 56.4
Mijia Wu
Director8.8yrsUS$40.58k0.0015%
$ 56.4
Pedram Hamrah
Member of Ophthalmic Advisory Board9.1yrsVeri yokVeri yok
Swan Sit
Independent Director4.9yrsUS$59.08k0.0015%
$ 56.4
Komal Thakore
Member of the Optometry Advisory Board4yrsVeri yokVeri yok
Amr Kouchouk
Member of the Ophthalmic Advisory Board4yrsVeri yokVeri yok
John Aljian
Member of the Ophthalmic Advisory Board4yrsVeri yokVeri yok
Laura Periman
Member of the Ophthalmic Advisory Board4yrsVeri yokVeri yok
Milap Mehta
Member of the Ophthalmic Advisory Board4yrsVeri yokVeri yok
Melanie Bennett-Sims
Member of the Ophthalmic Advisory Board4yrsVeri yokVeri yok

4.1yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NBY's board of directors are considered experienced (4.1 years average tenure).